FBR & Co set a $2.00 price target on Aemetis Inc. (NASDAQ:AMTX) in a research report released on Monday. The brokerage currently has a hold rating on the stock.
Separately, Zacks Investment Research raised Aemetis from a sell rating to a hold rating in a research note on Tuesday, November 8th.
Aemetis (NASDAQ:AMTX) opened at 1.82 on Monday. The company’s market cap is $36.14 million. Aemetis has a 52-week low of $1.01 and a 52-week high of $3.05. The company’s 50-day moving average price is $1.63 and its 200-day moving average price is $1.88.
Aemetis (NASDAQ:AMTX) last released its earnings results on Monday, November 14th. The company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.06. Equities research analysts expect that Aemetis will post ($1.04) EPS for the current fiscal year.
A hedge fund recently raised its stake in Aemetis stock. Geneva Advisors LLC boosted its position in shares of Aemetis Inc. (NASDAQ:AMTX) by 4.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,453,131 shares of the company’s stock after buying an additional 68,460 shares during the period. Geneva Advisors LLC owned about 7.32% of Aemetis worth $1,569,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 18.57% of the company’s stock.